Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Ani Pharmaceuticals Inc

NASDAQ: ANIP · Life Sciences · 10 alerts · CIK 1023024

Share price
$70.89Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ani Pharmaceuticals Inc filings on SEC EDGAR ↗

5:13 PM ET 8-K
M&A Deal

Ani Pharmaceuticals Signs $676M M&A Deal with Egetis Therapeutics AB

ANI Pharmaceuticals announced a recommended public cash offer to acquire all outstanding shares, convertibles, and warrants of Sweden-based Egetis Therapeutics AB. To finance the acquisition and refinance existing debt, ANI entered into a $676 million 364-day senior bridge credit facility with JPMorgan Chase Bank. The offer price is set at SEK 11.25 per share in cash.

Value
$676M
Counterparty
Egetis Therapeutics AB (publ)

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.